Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tipiracil

Catalog No. T60343 Copy Product Info
Purity: 99.81%
🥰Excellent
Tipiracil is a pharmacological agent that inhibits the enzyme thymidine phosphorylase. Tipiracil is under research for combination effect with trifluridine in advanced or metastatic colorectal and gastric cancers. By inhibiting thymidine phosphorylase, Tipiracil enhances the bioavailability and efficacy of trifluridine, offering alternative in cancer research.

Tipiracil

Copy Product Info
🥰Excellent
Catalog No. T60343

Tipiracil is a pharmacological agent that inhibits the enzyme thymidine phosphorylase. Tipiracil is under research for combination effect with trifluridine in advanced or metastatic colorectal and gastric cancers. By inhibiting thymidine phosphorylase, Tipiracil enhances the bioavailability and efficacy of trifluridine, offering alternative in cancer research.

Tipiracil
Cas No. 183204-74-2
Pack SizePriceUSA StockGlobal StockQuantity
2 mg$30In StockIn Stock
5 mg$43In StockIn Stock
10 mg$66In StockIn Stock
25 mg$98In StockIn Stock
50 mg$135In StockIn Stock
100 mg$178-In Stock
500 mg$395-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.81%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Tipiracil is a pharmacological agent that inhibits the enzyme thymidine phosphorylase. Tipiracil is under research for combination effect with trifluridine in advanced or metastatic colorectal and gastric cancers. By inhibiting thymidine phosphorylase, Tipiracil enhances the bioavailability and efficacy of trifluridine, offering alternative in cancer research.
In vitro
Tipiracil functions as a thymidine phosphorylase inhibitor, enhancing trifluridine's efficacy by impeding its metabolism via thymidine phosphorylase. This synergistic action facilitates the use of the Trifluridine-Tipiracil combination as an innovative oral treatment for metastatic colorectal cancer [2]. Additionally, Tipiracil fortifies the stability of FTD by mitigating its first-pass degradation through its inhibitory action on thymidine phosphorylase [3].
Chemical Properties
Molecular Weight242.66
FormulaC9H11ClN4O2
Cas No.183204-74-2
SmilesO=C1NC(=O)C(Cl)=C(N1)CN2C(=N)CCC2
Storage & Solubility Information
StorageShipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 0.8 mg/mL (3.3 mM), Sonication is recommended.
DMSO: < 1 mg/mL (insoluble)
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM4.1210 mL20.6050 mL41.2099 mL206.0496 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Tipiracil | purchase Tipiracil | Tipiracil cost | order Tipiracil | Tipiracil chemical structure | Tipiracil in vitro | Tipiracil formula | Tipiracil molecular weight